抗凝药在射频消融房颤后预防肺栓塞的应用进展  

Application of anticoagulant in the prevention of pulmonary embolism after radiofrequency ablation of atrial fibrillation

作　　者：宋瑞 阙静[2] 

机构地区：[1]河南中医药大学,2015级硕士研究生450000 [2]河南省人民医院,450000

出　　处：《中国老年保健医学》2017年第5期63-65,共3页Chinese Journal of Geriatric Care

摘　　要：射频消融已在心房颤动(简称房颤)、阵发性室上性心动过速及某些室性心律失常的治疗上得到广泛应用,肺栓塞是射频消融术后严重和潜在致命的并发症。抗凝治疗对于肺栓塞非常重要,目前各种各样的新型抗凝药物不断出现,现就新型口服抗凝药物和低分子肝素在射频消融术房颤后预防肺栓塞的应用进展做一综述。Radiofrequency ablation has been widely used in the treatment of paroxysmal supraventricular tachycardia, atrial fibrillation and certain ventricular arrhythmias. Pulmonary embolism is a serious and potentially fatal complication of radiofrequency ablation. Anticoagulants are important for the treatment of pulmonary embolism. In recent years, a variety of new anticoagulant drugs are emerging. The new oral anticoagulant and low molecular weight heparin are applied to prevention of pulmonary embolism after radiofrequency ablation , doing a review of the progress.

关 键 词：抗凝药 射频消融 房颤 肺栓塞 

分 类 号：R541.75[医药卫生—心血管疾病] R563.5[医药卫生—内科学]